• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性子宫腺肌病腹腔镜下部分切除术联合子宫动脉阻断术的临床应用及中期结果

Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.

作者信息

Kang Le, Gong Jun, Cheng Zhongping, Dai Hong, Liping Hu

机构信息

Department of Obstetrics and Gynecology, Yangpu Central Hospital, Shanghai, China.

出版信息

J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):169-73. doi: 10.1016/j.jmig.2008.12.003.

DOI:10.1016/j.jmig.2008.12.003
PMID:19249704
Abstract

STUDY OBJECTIVE

To examine the clinical application of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion (UAO).

DESIGN

Retrospective cohort study (Canadian Task Force classification III).

SETTING

A district hospital.

PATIENTS

A total of 37 patients with symptomatic adenomyosis who had indication for surgical intervention but needed conservative treatment.

INTERVENTION

Uterine artery occlusion combined with partial resection of adenomyosis via laparoscopy.

MEASUREMENTS AND MAIN RESULTS

From July 2003 through October 2005, 37 patients with symptomatic adenomyosis were treated by UAO combined with partial resection of adenomyosis via laparoscopy. All patients were followed up at 1, 6, and 12 months after the operation to estimate the volume of the uterus and changes of symptoms including pelvic pain and abnormal bleeding. Patients also were asked to participate in a clinical interview every year thereafter. No severe complications were noted during the surgical procedure or follow-up. The mean surgical time was 115.7 +/- 27.5 minutes (Mean +/- SD, 61-171 minutes), the mean blood loss was 80.0 +/- 35.2 mL (50-150 mL), and the median highest body temperature after the procedure was 38 degrees C (range 37.4 degrees C-39 degrees C). The postoperative fever morbidity was 10.8% (4/37). Improvement of menorrhagia occurred in all of 37 and 35 of 37 for dysmenorrhea. Hysterectomy was carried out in 2 patients because of persistence of dysmenorrhea. Pictorial blood loss assessment chart was used to measure menstrual blood loss and an 11-point numeric rating scale was used to evaluate the pain intensity during menstruation. The postoperative median scores of menorrhagia were 58, 56, and 59 at 1, 6, and 12 months, respectively, compared with 158 before treatment. Significant improvement occurred (p <.001, p <.001, p <.001), compared with each other, no significant difference existed (1 vs 6 months, p =.720; 6 vs 12 months, p =.992; 1 vs 12 months, p =.709). The postoperative median scores of dysmenorrhea were 7, 5, and 4 at 1, 6, and 12 months. Respectively, compared with 8 before operation; significant symptom lessening occurred (p <.001, p <.001, p <.001). Comparing with each other, significant difference also existed (1 vs 6 months, p <.001; 6 vs 12 months, p <.001; 1 vs 12 months, p =.0018). The volume of the uterus before procedure was 224.6 +/- 48.7 cm(3) (156.0-336.1 cm(3)). At 6 and 12 months it was 169.2 +/- 78.1 cm(3) (118.4-218.2 cm(3)) and 91.6 +/- 28.4 cm(3) (43.1-127.5 cm(3)), respectively. At 6 months after surgery the volume of uterus shrank 24.7% compared with preoperative volume; shrinkage rate was 59.2% at 12 months after surgery. A continuous decrease occurred (p <.001, p <.001, p <.001).

CONCLUSION

Laparoscopic partial resection of adenomyosis combined with UAO is an effective treatment modality for symptomatic adenomyosis, but further controlled studies with large samples and long-term follow-up is needed for a decisive conclusion.

摘要

研究目的

探讨腹腔镜下症状性子宫腺肌病部分切除术联合子宫动脉阻断术(UAO)的临床应用。

设计

回顾性队列研究(加拿大工作组分类III级)。

地点

一家区级医院。

患者

共有37例有症状性子宫腺肌病且有手术干预指征但需要保守治疗的患者。

干预措施

子宫动脉阻断联合腹腔镜下子宫腺肌病部分切除术。

测量指标及主要结果

2003年7月至2005年10月,37例有症状性子宫腺肌病患者接受了UAO联合腹腔镜下子宫腺肌病部分切除术。所有患者在术后1、6和12个月进行随访,以评估子宫体积以及包括盆腔疼痛和异常出血在内的症状变化。此后每年还要求患者参加一次临床访谈。手术过程中及随访期间均未发现严重并发症。平均手术时间为115.7±27.5分钟(平均±标准差,61 - 171分钟),平均失血量为80.0±35.2毫升(50 - 150毫升),术后最高体温中位数为38℃(范围37.4℃ - 39℃)。术后发热发生率为10.8%(4/37)。37例患者的月经过多均有改善,37例中有35例痛经得到改善。2例患者因痛经持续存在而行子宫切除术。采用图像失血评估图测量月经量,并采用11分数字评分量表评估月经期间的疼痛强度。术后月经过多的中位数评分在1、6和12个月时分别为58、56和59,而治疗前为158。与治疗前相比有显著改善(p <.001,p <.001,p <.001),相互比较,无显著差异(1个月与6个月,p = 0.720;6个月与12个月,p = 0.992;1个月与12个月,p = 0.709)。术后痛经的中位数评分在1、6和12个月时分别为7、5和4,术前为8;症状明显减轻(p <.001,p <.001,p <.001)。相互比较也有显著差异(1个月与6个月,p <.001;6个月与12个月,p <.001;1个月与12个月,p = 0.0018)。术前子宫体积为224.6±48.7立方厘米(156.0 - 336.1立方厘米)。在6个月和12个月时分别为169.2±78.1立方厘米(118.4 - 218.2立方厘米)和91.6±28.4立方厘米(43.1 - 127.5立方厘米)。术后6个月子宫体积较术前缩小24.7%;术后12个月缩小率为59.2%。子宫体积持续减小(p <.001,p <.001,p <.001)。

结论

腹腔镜下子宫腺肌病部分切除术联合UAO是治疗症状性子宫腺肌病的一种有效治疗方式,但需要进一步进行大样本、长期随访的对照研究才能得出决定性结论。

相似文献

1
Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.症状性子宫腺肌病腹腔镜下部分切除术联合子宫动脉阻断术的临床应用及中期结果
J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):169-73. doi: 10.1016/j.jmig.2008.12.003.
2
Surgical treatment of endometriosis in private practice: cohort study with mean follow-up of 3 years.私人执业中子宫内膜异位症的手术治疗:平均随访 3 年的队列研究。
J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):42-6. doi: 10.1016/j.jmig.2009.09.019.
3
Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis.腹腔镜双侧子宫动脉阻断术联合有症状子宫腺肌病部分切除术的长期疗效及生活质量
Eur J Obstet Gynecol Reprod Biol. 2014 May;176:20-4. doi: 10.1016/j.ejogrb.2013.11.014. Epub 2013 Dec 17.
4
Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.腹腔镜子宫动脉阻断术联合保留子宫的盆腔丛阻滞及部分子宫肌腺瘤切除术治疗子宫腺肌病:1 例视频病例报告。
J Minim Invasive Gynecol. 2021 Oct;28(10):1681-1684. doi: 10.1016/j.jmig.2021.05.015. Epub 2021 May 26.
5
Uterine adenomyosis in persistence of dysmenorrhea after surgical excision of pelvic endometriosis and colorectal resection.盆腔子宫内膜异位症手术切除及结直肠切除术后痛经持续存在中的子宫腺肌病
J Reprod Med. 2009 Jun;54(6):366-72.
6
Uterine artery embolization for adenomyosis without fibroids.子宫肌瘤剔除术后子宫腺肌病的子宫动脉栓塞术。 你提供的原文似乎不太完整或存在一些混淆,“Uterine artery embolization for adenomyosis without fibroids.”从字面看意思不太清晰,我猜测你可能想表达的是“子宫动脉栓塞术治疗无子宫肌瘤的子宫腺肌病”,我按照这个理解进行了翻译,你可以检查一下是否符合你的需求。如果不是,请提供更准确的原文信息。
Clin Radiol. 2004 Jun;59(6):520-6. doi: 10.1016/j.crad.2003.11.018.
7
Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.使用校准的三丙烯酸明胶微球对有症状的子宫腺肌病伴或不伴子宫肌瘤进行子宫动脉栓塞术:中期临床及磁共振成像随访
J Vasc Interv Radiol. 2007 Jul;18(7):835-41. doi: 10.1016/j.jvir.2007.04.024.
8
Laparoscopic-assisted vaginal hysterectomy with uterine artery ligation through retrograde umbilical ligament tracking.经逆行脐韧带追踪行子宫动脉结扎的腹腔镜辅助阴式子宫切除术
J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):336-42. doi: 10.1016/j.jmig.2005.05.006.
9
Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.左炔诺孕酮宫内节育器对子宫腺肌病患者的临床疗效。
Am J Obstet Gynecol. 2008 Apr;198(4):373.e1-7. doi: 10.1016/j.ajog.2007.10.798. Epub 2008 Feb 21.
10
The influence of adenomyosis in patients laparoscopically treated for deep endometriosis.子宫腺肌病对接受腹腔镜治疗深部子宫内膜异位症患者的影响。
J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):566-70. doi: 10.1016/j.jmig.2008.06.009.

引用本文的文献

1
Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence.子宫腺肌病和异常子宫出血:证据综述。
Biomolecules. 2024 May 23;14(6):616. doi: 10.3390/biom14060616.
2
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis.亚洲子宫内膜异位症和子宫腺肌病学会子宫腺肌病管理指南
Reprod Med Biol. 2023 Sep 10;22(1):e12535. doi: 10.1002/rmb2.12535. eCollection 2023 Jan-Dec.
3
A Video Article: The Laparoscopic Uterine Artery Occlusion in Combination with Myomectomy for Uterine Myoma.视频文章:腹腔镜下子宫动脉阻断联合子宫肌瘤切除术治疗子宫肌瘤
Gynecol Minim Invasive Ther. 2022 May 4;11(2):114-115. doi: 10.4103/GMIT.GMIT_10_21. eCollection 2022 Apr-Jun.
4
A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis.一项关于子宫腺肌病保留子宫治疗研究中结局报告和结局指标的系统评价。
Hum Reprod Open. 2021 Aug 7;2021(3):hoab030. doi: 10.1093/hropen/hoab030. eCollection 2021.
5
Current and Prospective Treatment of Adenomyosis.子宫腺肌病的当前及未来治疗
J Clin Med. 2021 Jul 30;10(15):3410. doi: 10.3390/jcm10153410.
6
Cervical Cancer Surgery: Current State of Affairs.宫颈癌手术:现状
Gynecol Minim Invasive Ther. 2021 Apr 30;10(2):75-83. doi: 10.4103/GMIT.GMIT_81_20. eCollection 2021 Apr-Jun.
7
Eutopic/ectopic endometrial apoptosis initiated by bilateral uterine artery occlusion: A new therapeutic mechanism for uterus-sparing surgery in adenomyosis.双侧子宫动脉阻断引发的在位/异位子宫内膜凋亡:子宫腺肌病保留子宫手术的一种新治疗机制。
PLoS One. 2017 Apr 13;12(4):e0175511. doi: 10.1371/journal.pone.0175511. eCollection 2017.
8
Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis.双瓣法腹腔镜下子宫腺肌病切除术治疗弥漫性子宫腺肌病的疗效
BMC Womens Health. 2015;15:24. doi: 10.1186/s12905-015-0182-5. Epub 2015 Mar 13.